Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 91999E000596

WRITTEN QUESTION No. 596/99 by Ian WHITE Growth hormone rBST

UL C 370, 21.12.1999, p. 68 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)

European Parliament's website

Date of document:
12/03/1999; datum pošiljanja:
Date of dispatch:
12/03/1999
Date of reply:
04/05/1999; ?
Author:
Evropski parlament, WHITE
Form:
Pisno vprašanje
Parliamentary term:
Četrto zakonodajno obdobje
Political group:
Skupina socialdemokratov v Evropskem parlamentu
Link
Link
Link
Select all documents mentioning this document
Instruments cited:
Link

91999E0596

WRITTEN QUESTION No. 596/99 by Ian WHITE Growth hormone rBST

Official Journal C 370 , 21/12/1999 P. 0068


WRITTEN QUESTION E-0596/99

by Ian White (PSE) to the Commission

(12 March 1999)

Subject: Growth hormone rBST

1. Will the Commission insist that the relevant committees study all evidence concerning the impact on both animal and human health of the growth hormone rBST when the company that owns this drug applies for a licence to sell it for use within the EU?

2. Will the Commission follow the precautionary principle when the issue of granting the licence to sell the bovine growth hormone rBST is brought up?

Answer given by Mr Fischler on behalf of the Commission

(4 May 1999)

The Commission asked for an opinion from the specific veterinary committee on animal health and animal welfare, as well as from the scientific committee on public health, regarding the use of BST. Each of the two scientific committees has recently issued a scientific opinion relating to their specific tasks. The opinions are available on the Commission's Europa server. Based on these conclusions of the scientific opinions, the Commission, with a view to a decision being taken on this matter, will submit a report and a proposal on the future of the moratorium on bovine somatotrophin (Council Decision 94/936/EC)(1) to the Council and the Parliament.

(1) OJ L 366, 31.12.1994.

Top